REQUEST A DEMO
Total
USD $0.00
Search more companies

Natco Lifesciences Philippines Inc. (Philippines)

Main Activities: Offices of Physicians | Outpatient Care Centers | Hospitals
Full name: Natco Lifesciences Philippines Inc. Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Natco Lifesciences Philippines Inc. is a company based in Philippines, with its head office in Manila. The enterprise operates in the Offices of Physicians industry. It was incorporated on March 22, 2018. From the latest financial highlights, Natco Lifesciences Philippines Inc. reported a net sales revenue increase of 48.34% in 2024. There was a total growth of 57.91% in Natco Lifesciences Philippines Inc.’s total assets over the same period. In 2024, Natco Lifesciences Philippines Inc.’s net profit margin decreased by 1.71%.

Headquarters
Unit 1-B Ground Floor Manor Building 2629 Taft Avenue
Manila; National Capital Region; Postal Code: 1000

Contact Details: Purchase the Natco Lifesciences Philippines Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Natco Lifesciences Philippines Inc. report to view the information.
Incorporation Date:
March 22, 2018
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Natco Lifesciences Philippines Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
48.34%
Total Operating Revenue
48.34%
Net Profit/Loss for the Period
26.64%
Total Assets
57.91%
Total Equity
85.78%
Net Profit Margin
-1.71%
Return on Equity (ROE)
-7.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?